http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
role of neuropeptides in addiction and disorders of excessive consumption
""Front Cover""; ""The Role of Neuropeptides in Addiction and Disorders of Excessive Consumption""; ""Copyright""; ""Contents""; ""Contributors""; ""Preface""; ""Chapter One: Neuropeptides and Addiction: An Introduction""; ""References""; ""Chapter Two: Corticotropin-Releasing Factor (CRF) and Addictive Behaviors""; ""1. Introduction""; ""2. CRF Stress Systems""; ""3. CRF, the HPA Axis, and Addiction""; ""4. Extrahypothalamic CRF Systems""; ""5. Role for CRF-CRF1 Systems in Animal Models of Addiction""; ""6. Central Extended Amygdala""; ""6.1. Cellular Mechanisms of CRF""
""7. Ventral Tegmental Area""""8. Prefrontal Cortex""; ""9. Compulsive Eating""; ""10. Conclusion""; ""Acknowledgments""; ""References""; ""Chapter Three: Dynorphin/Kappa Opioid Receptor Signaling in Preclinical Models of Alcohol, Drug, and Food Addiction""; ""1. Introduction""; ""1.1. Stress, Addiction, and Kappa Opioid Receptors""; ""1.2. Modulation of Neurotransmitter Signaling by Kappa Opioid Receptors""; ""1.3. Kappa Opioid Receptors in the NAc""; ""1.4. Kappa Opioid Receptors in the VTA""; ""1.5. Measuring Dynorphin Levels""; ""1.6. Opponent Process Theory of Addiction""
""1.7. Sex Differences in Kappa Opioid Receptor Function""""2. Ethanol and Kappa Opioid Receptors""; ""2.1. Kappa Opioid Receptors and Ethanol Consumption""; ""2.2. Kappa Opioid Receptors and Chronic Ethanol Exposure""; ""2.3. Ethanol Effects on the Dynorphin/Kappa Opioid Receptor System""; ""2.4. Ethanol, Kappa Opioid Receptors, and Dopamine""; ""3. Cocaine and Kappa Opioid Receptors""; ""3.1. Chronic Stress, Kappa Opioid Receptors, and Cocaine""; ""3.2. Timing of Kappa Opioid Receptor Activation, Dopamine Deficits, and Cocaine Effects""; ""3.3. Kappa Opioid Receptors and DATs""
""3.4. Cocaine, Kappa Opioid Receptors, and DATs""""3.5. Reinstatement of Cocaine Self-Administration""; ""4. Obesity and Kappa Opioid Receptors""; ""4.1. The Dynorphin/Kappa Opioid Receptor System and Hereditary Obesity""; ""4.2. Dynorphin/Kappa Opioid Receptor System and Palatable Food Consumption""; ""4.3. Dynorphin/Kappa Opioid Receptor System and Food Deprivation""; ""5. Kappa Opioid Receptor-Based Therapeutics""; ""References""; ""Further Reading""; ""Chapter Four: The Role of the Ghrelin System in Drug Addiction""; ""1. Introduction""; ""2. Ghrelin and Alcohol""
""2.1. Preclinical Evidence""""2.2. Clinical Evidence""; ""3. Ghrelin and Stimulants""; ""3.1. Preclinical Evidence""; ""3.2. Clinical Evidence""; ""4. Ghrelin and Tobacco/Nicotine""; ""4.1. Preclinical Evidence""; ""4.2. Clinical Evidence""; ""5. Ghrelin and Opioids""; ""5.1. Preclinical Evidence""; ""6. Ghrelin and Cannabis""; ""6.1. Preclinical Evidence""; ""6.2. Clinical Evidence""; ""7. Conclusions""; ""Acknowledgments and Disclosures""; ""References""; ""Chapter Five: The Role of the Melanocortin System in Drug and Alcohol Abuse""; ""1. Introduction""; ""2. Melanocortin Receptors""
SCIENCE / Life Sciences / Zoology / Mammals
International review of neurobiology ; v. 136